Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future Challenges

Jordi Remon1, Stephanie P.L. Saw2, Francesco Cortiula3, Pawan Kumar Singh4, Jessica Menis5, Giannis Mountzios6, Lizza E.L. Hendriks7
1Department of Cancer Medicine, Gustave Roussy, Villejuif, France
2Department of Medical Oncology, National Cancer Centre Singapore, Duke–National University of Singapore Oncology Academic Clinical Programme, Singapore
3Department of Oncology, University Hospital of Udine, Udine, Italy
4Pandit Bhagwat Dayal Sharma Postgraduate Institute of Medical Science, Rothak, India
5Medical Oncology Department, University and Hospital Trust of Verona, Verona, Italy
6Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece
7Department of Respiratory Medicine, Maastricht University Medical Centre, GROW School for Oncology and Reproduction, Maastricht, The Netherlands